Consolidated Statement Of Cash Flows

Carna Biosciences, Inc. - Filing #7736495

Concept As at
2017-06-30
2017-01-01 to
2017-06-30
As at
2016-12-31
As at
2016-06-30
2016-01-01 to
2016-06-30
As at
2015-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-314,968,000 JPY
-32,607,000 JPY
Depreciation
7,206,000 JPY
9,947,000 JPY
Impairment losses
17,649,000 JPY
1,624,000 JPY
Interest expenses
3,540,000 JPY
1,504,000 JPY
Foreign exchange losses (gains)
1,438,000 JPY
15,680,000 JPY
Subtotal
-230,990,000 JPY
-137,705,000 JPY
Decrease (increase) in trade receivables
48,809,000 JPY
122,003,000 JPY
Decrease (increase) in inventories
6,906,000 JPY
17,498,000 JPY
Net cash provided by (used in) operating activities
-222,568,000 JPY
-164,107,000 JPY
Increase (decrease) in trade payables
-2,491,000 JPY
-15,260,000 JPY
Other, net
22,201,000 JPY
-39,499,000 JPY
Interest paid
-3,454,000 JPY
-1,927,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-28,621,000 JPY
-27,248,000 JPY
Net cash provided by (used in) investing activities
-28,738,000 JPY
254,628,000 JPY
Proceeds from sale of investment securities
JPY
281,876,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
400,000,000 JPY
Repayments of long-term borrowings
-71,130,000 JPY
-43,348,000 JPY
Redemption of bonds
-14,014,000 JPY
JPY
Net cash provided by (used in) financing activities
-15,582,000 JPY
625,025,000 JPY
Other, net
-99,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
-1,877,000 JPY
-19,748,000 JPY
Net increase (decrease) in cash and cash equivalents
-268,766,000 JPY
695,797,000 JPY
Cash and cash equivalents
1,892,419,000 JPY
2,161,186,000 JPY
2,320,738,000 JPY
1,624,941,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.